The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
![](https://webarchive.library.unt.edu/web/20120926114732im_/http://www.cancer.gov/images/spacer.gif)
falimarev
A cancer vaccine comprised of a recombinant fowlpox viral vector encoding the carcinoembryonic antigen (CEA), MUC-1, a transmembrane glycoprotein secreted by glandular epithelial tissues, and TRICOM, comprised of three co-stimulatory molecule transgenes (B7-1, ICAM-1 and LFA-3). This agent may enhance CEA and MUC-1 presentation to antigen-presenting cells (APC) and may activate a cytotoxic T-cell response against CEA- and MUC-1-expressing tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/web/20120926114732im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![]() | recombinant fowlpox-CEA-MUC-1-TRICOM vaccine rfowlpox-CEA(D609)/MUC1(L93)/TRICOM vaccine | |
![]() | |||
US brand name: | ![]() | PANVAC-F | |
![]() | |||
Abbreviation: | ![]() | fCEA-MUC-1-TRI | |
![]() |